Literature DB >> 7107842

Evaluation of two Salmonella typhi strains with reduced virulence for use in teaching and proficiency testing.

F W Hickman, D L Rhoden, A O Esaias, L S Baron, D J Brenner, J J Farmer.   

Abstract

A total of 21 cases of laboratory-acquired typhoid fever associated with teaching and proficiency tests occurred in the United States during a 33-month period, prompting a search for less virulent strains of S. typhi which would be suitable for teaching purposes. Two strains were evaluated which are reported to have reduced virulence for mice. Strain Ty21a is a genetically constructed mutant that lacks the enzyme UDP-glucose-4-epimerase. This strain has reduced virulence for humans if grown under special laboratory conditions (in the presence of 0.1% d-galactose) and has been evaluated as a candidate for use as a live, oral vaccine. Strain H901 was originally isolated in Russia in 1918. It has not been tested in humans, but its nonmotile variant, O901, has been found to be somewhat less virulent for humans; however, it can cause infection with doses of 10(7) organisms. In teaching exercises, all strains should be treated as though they are fully virulent. Ty21a and H901 were satisfactory, but not ideal, for teaching purposes. Biochemically, they could be identified by conventional tests and by commercially available diagnostic systems, although Ty21a was H(2)S negative. Serologically, both strains posed problems. Both Ty21a and H901 were Vi antigen negative, and Ty21a was rough and grew poorly. Both strains were susceptible to antibiotics, including chloramphenicol, ampicillin, and trimethoprim-sulfameth-oxazole. When Ty21a and H901 were mixed with Escherichia coli and plated, Hektoen and salmonella-shigella agars were most useful for their recovery. The appearance of Ty21a and H901 on differential plating media was typical, although Ty21a had smaller colonies. The plating efficiency on MacConkey agar for Ty21a was 0.6 compared with 1 for H901. Neither strain can be recommended unequivocally for teaching purposes; instead, the advantages and disadvantages of each must be considered. Both strains have been deposited in the American Type Culture Collection (Ty21a = ATCC 33459 = CDC 2861-79; H901 = ATCC 33458 = CDC 2862-79).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7107842      PMCID: PMC272258          DOI: 10.1128/jcm.15.6.1085-1091.1982

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  7 in total

1.  Studies on the virulence of a naturally occurring mutant of Salmonella typhosa.

Authors:  S B FORMAL; L S BARON; W SPILMAN
Journal:  J Bacteriol       Date:  1954-07       Impact factor: 3.490

Review 2.  Typhoid fever: pathogenesis and immunologic control.

Authors:  R B Hornick; S E Greisman; T E Woodward; H L DuPont; A T Dawkins; M J Snyder
Journal:  N Engl J Med       Date:  1970-09-24       Impact factor: 91.245

3.  Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine.

Authors:  R Germanier; E Füer
Journal:  J Infect Dis       Date:  1975-05       Impact factor: 5.226

4.  Salmonella typhi: identification, antibiograms, serology, and bacteriophage typing.

Authors:  F W Hickman; J J Farmer
Journal:  Am J Med Technol       Date:  1978-12

5.  Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccine.

Authors:  R H Gilman; R B Hornick; W E Woodard; H L DuPont; M J Snyder; M M Levine; J P Libonati
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

6.  Studies of immunity in typhoid fever. Protection induced by killed oral antigens or by primary infection.

Authors:  H L Dupont; R B Hornick; M J Snyder; A T Dawkins; G G Heiner; T E Woodward
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

7.  Salmonella typhi: the laboratory as a reservoir of infection.

Authors:  M J Blaser; F W Hickman; J J Farmer; D J Brenner; A Balows; R A Feldman
Journal:  J Infect Dis       Date:  1980-12       Impact factor: 5.226

  7 in total
  3 in total

1.  Salmonella enterica serovar Typhi possesses a unique repertoire of fimbrial gene sequences.

Authors:  S M Townsend; N E Kramer; R Edwards; S Baker; N Hamlin; M Simmonds; K Stevens; S Maloy; J Parkhill; G Dougan; A J Bäumler
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  Salmonella typhi 205aTy, a strain with two attenuating auxotrophic characters, for use in laboratory teaching.

Authors:  R F Brown; B A Stocker
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

3.  Laboratory-acquired infections of Salmonella enterica serotype Typhi in South Africa: phenotypic and genotypic analysis of isolates.

Authors:  Anthony Marius Smith; Shannon Lucrecia Smouse; Nomsa Pauline Tau; Colleen Bamford; Vineshree Mischka Moodley; Charlene Jacobs; Kerrigan Mary McCarthy; Adré Lourens; Karen Helena Keddy
Journal:  BMC Infect Dis       Date:  2017-09-29       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.